# Epizyme funding: rounds and investors > Epizyme has raised $332M across 6 rounds since 2009. Investors include New Enterprise Associates, Kleiner Perkins Caufield & Byers and MPM Capital. Source: https://millionrounds.com/company/epizyme (Millionrounds; every figure on the page links to its filing or article) United States · [Funded startup](https://millionrounds.com/companies) # Who invested in *Epizyme* 6 rounds we have observed, with the 11 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it. Biotech Healthcare Funding summary Updated 26 Oct 2026 **$332M** raised across 6 rounds since 2009, from 6 sources **$32M** Series B **$8.0M** Series B **$7.5M** Venture **$4.0M** Venture **$10M** Round **$270M** Round - **Latest round:** Round, $270M Nov 2019 - **Step-up i:** 27× - **Investors:** 11 See who backed them ## The funding story Each circle is a round, placed by date and sized by amount. The line above is the running total. 2011 2013 2015 2017 2019 **$32M** Series B **$8.0M** Series B **$7.5M** Venture **$4.0M** Venture **$10M** Round **$270M** Round - **First round:** Series B, $32M - **Biggest round:** $270M - **Usual gap between rounds:** 18 months ## The rounds - **Nov 2019** Round **$270M** *2 new* [Royalty Pharma](https://millionrounds.com/fund/royalty-pharma) Pharmakon Advisors Reported by FinSMEs - **Feb 2014** Round **$10M** *1 new* [Celgene](https://millionrounds.com/fund/celgene) From a historical funding record - **Oct 2011** Venture **$4.0M** *1 new* [GlaxoSmithKline](https://millionrounds.com/fund/glaxosmithkline) Reported by epizyme.com - **Jun 2011** Venture **$7.5M** *1 new* [Leukemia & Lymphoma Society](https://millionrounds.com/fund/leukemia-and-lymphoma-society) Reported by masshightech.com - **Dec 2009** Series B **$8.0M** *1 new* [New Enterprise Associates](https://millionrounds.com/fund/new-enterprise-associates) Reported by fiercebiotech.com - **Oct 2009** Series B **$32M** *5 new* [Kleiner Perkins Caufield & Byers](https://millionrounds.com/fund/kleiner-perkins-caufield-and-byers) [MPM Capital](https://millionrounds.com/fund/mpm-bioimpact) [Bay City Capital](https://millionrounds.com/fund/bay-city-capital) [Amgen](https://millionrounds.com/fund/amgen) [Astellas Venture Management](https://millionrounds.com/fund/astellas-venture-management) Reported by fiercebiotech.com ## Who was in which round The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led. **Series B** 2009 **Series B** 2009 **Venture** 2011 **Venture** 2011 **Round** 2014 **Round** 2019 [New Enterprise Associates](https://millionrounds.com/fund/new-enterprise-associates) [Kleiner Perkins Caufield & Byers](https://millionrounds.com/fund/kleiner-perkins-caufield-and-byers) [MPM Capital](https://millionrounds.com/fund/mpm-bioimpact) [Bay City Capital](https://millionrounds.com/fund/bay-city-capital) [Amgen](https://millionrounds.com/fund/amgen) [Celgene](https://millionrounds.com/fund/celgene) [Astellas Venture Management](https://millionrounds.com/fund/astellas-venture-management) [GlaxoSmithKline](https://millionrounds.com/fund/glaxosmithkline) [Royalty Pharma](https://millionrounds.com/fund/royalty-pharma) [Leukemia & Lymphoma Society](https://millionrounds.com/fund/leukemia-and-lymphoma-society) ## The exit Exit Listing Price When IPO NASDAQ:EPZM $60M May 2013 From historical deal records. Wrong? [Tell us](https://millionrounds.com/corrections?slug=epizyme). ## Everyone who backed them [New Enterprise Associates](https://millionrounds.com/fund/new-enterprise-associates) VC firm **1** round [Kleiner Perkins Caufield & Byers](https://millionrounds.com/fund/kleiner-perkins-caufield-and-byers) VC firm **1** round [MPM Capital](https://millionrounds.com/fund/mpm-bioimpact) Private equity **1** round [Bay City Capital](https://millionrounds.com/fund/bay-city-capital) VC firm **1** round [Amgen](https://millionrounds.com/fund/amgen) Corporate VC **1** round [Celgene](https://millionrounds.com/fund/celgene) Growth equity **1** round [Astellas Venture Management](https://millionrounds.com/fund/astellas-venture-management) Corporate VC **1** round [GlaxoSmithKline](https://millionrounds.com/fund/glaxosmithkline) VC firm **1** round [Royalty Pharma](https://millionrounds.com/fund/royalty-pharma) Growth equity **1** round [Leukemia & Lymphoma Society](https://millionrounds.com/fund/leukemia-and-lymphoma-society) Investment firm **1** round Pharmakon Advisors no record of our own yet **1** round Missing a round, or an investor who was in one? [Tell us](https://millionrounds.com/corrections?slug=epizyme). ## Quick answers about Epizyme ### Who invested in Epizyme? Epizyme's investors include New Enterprise Associates, Kleiner Perkins Caufield & Byers, MPM Capital, Bay City Capital and Amgen, and 6 more on record. ### How much has Epizyme raised? Epizyme has raised $332M across 6 rounds since 2009. ### When did Epizyme last raise? Epizyme's most recent round was an Undisclosed round of $270M in Nov 2019. ### What was Epizyme's biggest round? Its most recent round, $270M in Nov 2019, is also its largest on record. ### Who backed Epizyme first? Epizyme's first round on record, in Oct 2009, was backed by Kleiner Perkins Caufield & Byers, MPM Capital and Bay City Capital and 2 others. ### What stage is Epizyme at? Epizyme's latest named round is an Undisclosed round, in Nov 2019. ### Where is Epizyme based? Epizyme is based in the United States. ## Companies like Epizyme In the same sector, and raised in the last eighteen months. [**Star Therapeutics** $325M · Oct 2026](https://millionrounds.com/company/star-therapeutics)[**Promaxo** $106M · Oct 2026](https://millionrounds.com/company/promaxo)[**Prolific Machines** $105M · Oct 2026](https://millionrounds.com/company/prolific-machines)[**AI** $18M · Oct 2026](https://millionrounds.com/company/ai)[**Baba** $40M · Oct 2026](https://millionrounds.com/company/baba)[**IMIO** $19M · Oct 2026](https://millionrounds.com/company/imio) ## Find investors like these Search every investor by what they have actually funded, then narrow to your stage and market. Free. Open the investor searchOr these rounds in the app